Gemcitabine elaidate

DB12564InvestigationalSmall molecule

Gemcitabine elaidate has been used in trials studying the treatment of Solid Tumor, Lung Cancer, Non-small-cell Lung Cancer, and Metastatic Pancreatic Adenocarcinoma.

Formula / weight: C₂₇H₄₃F₂N₃O₅ · 527.654 g/mol (avg)
Also known as: 5'-O-(TRANS-9''-OCTADECENOYL)-1-.BETA.-D-2'DEOXY-2',2'-DIFLUOROCYTIDINE
Code names: CO-1.01 · CP-4126

Resolves to

Compound

UNII231C73W7LGCAS210829-30-4ChEMBLCHEMBL3039516ChEBI177710PubChem9828310

Structure

InChIKeyHESSNRGIEVBPRB-QDDPNBLJSA-NSMILESCCCCCCCC\C=C\CCCCCCCC(=O)OC[C@H]1O[C@@H](N2C=CC(N)=NC2=O)C(F)(F)[C@@H]1O

Targets

P31350RRM2

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Gemcitabine elaidate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account